CEO, Founder | Lisa Sakashita
M. S. degree from department of Physics, the University of Tokyo. B. S. degree from department of Physics, Tokyo University of Science. Her career includes: Nomura Securities, Co., Ltd. (analyst, Investment Banking division.), Bloomberg LLP (data analyst), Ginza Galleries (International Public Relations/Overseas Project Integration) and Linkers Corporation (Managing Executive Officer). At Linkers Corporation, a start-up company in the technology matching service industry, she won MVP for top sales.
CTO | Jinsei Miyazaki
B. E., and M. E. degree from Faculty of Technology, Kyoto University.
Gust scientist of Max-Planck Institute of Bio-Physical Chemistry in 1989-1991.
1981: Joined Matsushita Electric Industries (Panasonic, as of now) and consistently kept cultivating new technology fields including immuno-chemical sensing. 2002: Established tele-healthcare based joint venture, Viterion LLC, in NY USA, and served as CTO. After return back to Japan in 2006, managed variety of medical equipments as the GM of engineering group, AA-SBU Panasonic Healthcare Co. Ltd. Transferred to Meiji Seika Pharma according to the assignment of laser technology of Photodynamic therapy against cancers in 2015.
Technology Director | Naoyuki Sekioka Ph.D.
He received a Ph.D. degree from Pure and Applied Sciences, University of Tsukuba.2012-2018, Visiting Researcher, Nihon University.In 2009, he joined a clinical laboratory analyzer manufacturer and engaged in the development of clinical laboratory biosensors and testing equipment. In 2021, he became the development group leader and continued to be in charge of new product development of clinical laboratory analyzers.He sympathized with Nanotis' concept realizing high-sensitivity and rapid testing, and joined as a Technology Director of Nanotis in 2022.
Researcher | Yoko Nagai
As an engineer, Nagai has been engaged in general equipment analyses and drug R&D in the field of biochemistry for 12 years at major pharmaceutical companies and a food manufacturer, etc. After graduating from university, she joined a national project team of Keio University. Then, she was engaged in R&D of injectables for hepatitis C and osteoporosis at a major domestic pharmaceutical company, and assessment of adverse drug reaction cases at a foreign pharmaceutical company.
Nagai joined Nanotis due to her deep affinity with our mission concept of "Whenever, Wherever, and Whoever."
CEO Assistant | Ayumi Akiba
Member of the Board | Koji Nakao
Corporate adviser of Terumo Corporation
Chairman of The Japan Federation of Medical Devices Associations
Chairman of Medical Technology Association of Japan
Director of The Japan Association for Medtech Innovation
B. L. degree from the Faculty of Law, Keio University. Nakao started his career at Terumo Corporation in 1970. Then he successively assumed the posts of Chairman & CEO of Terumo Medical Corporation (US), and Director, Vice President, and Executive Officer at Terumo Corporation. He was then elected as Chairman of the Board of the company in 2011. Since 2016, he has been the Corporate Adviser of Terumo Corporation.
Member of the Board | Toshiaki Masuda
Managing Director of Nipro Corporation Medical Technology Division for Planning,Development & Marketing; Research &Development Center
Joined Nipro Corporation in 1975. Assumed his current position in 2022 after working as General Manager of Dialysis Product Sales Department, General Manager of Product Development Sales Department, Managing Director and General Manager of Research Institute.
Scientific Founder | Michika Onoda Ph.D.
Dr. Michika Onoda is a Postdoctoral Researcher at Massachusetts Institute of Technology.
He received a Ph. D. degree from faculty of Materials Engineering, the University of Tokyo (Top Graduate, President's Award). His career includes JSPS Research Fellow DC1 (2016), Visiting Researcher at University of Minnesota (2017), JSPS Superlative Postdoctoral Fellow at Nagoya University (2019 to present), and Postdoctoral Researcher at Massachusetts Institute of Technology (2019 to present).
The target of his research is to create novel functional polymeric materials, especially in the field of the polymer gel. In his career, he won more than eighteen awards at national and international conferences including the University of Tokyo President's Award for the outstanding research about artificial amoeba utilizing polymeric fluids. In addition to his research, he established science media and works as a writer collaborating with 2Dfacto, Inc.
Technical Advisor | Teruyuki Nagamune Ph.D.
B. S., M. S., and Ph. D. degree from school of Chemical Engineering, Tokyo Institute of Technology in 1973, 1975, and 1985. His career includes: RIKEN (Research Scientist from 1977), University of Illinois (Visiting Researcher from 1988), RIKEN (Vice Senior Research Scientist from 1992), the University of Tokyo (Professor from 1993). Dr. Nagamune is the winner of the 25th Ichimura Award (1993), The SCEJ Award (Tamaki Medal) (2002), Ichimura Prize, IUPAC Fellow on Biotechnology, The SCEJ Award (Ikeda Medal) (2014), etc.
Collaborator | Yoshida-Akimoto lab., the Univ. of Tokyo
The target of the research group is to create novel bio-inspired materials exhibiting dynamic properties inspired by self-organized biomimetic characters of living organisms.
Yoshida-Akimoto lab. Home Page
Ryo Yoshida, Ph. D.
Dr. Ryo Yoshida is a full professor at The University of Tokyo. He received a Ph.D. degree in chemical engineering in 1993 from Waseda University, Japan. He was a research associate at Tokyo Women’s Medical University in 1993, a researcher at the National Institute of Materials and Chemical Research from 1994–1997, and an assistant professor at University of Tukuba from 1997–2000. In 2001, he moved to The University of Tokyo as an associate professor and became a full professor in 2012. He won the Society of Polymer Science, Japan Wiley Award in 2009.
Collaborator | Norio Omagari M.D., M.Sc., Ph.D.
Desease Control and Prevention Center
Dr. Norio Omagari graduated from Saga Medical School’s Faculty of Medicine, Saga University in 1997.
In the same year, he joined St. Luke's International Hospital as a resident, and then became a general internal medicine staff member. Thereafter, he joined Aida Memorial Hospital in 2001 and the Division of Infectious Diseases at the University of Texas-Houston Medical School in 2002. From 2004 to 2010, he assumed the posts of Senior Staff and Chief in the Division of Infectious Diseases at Shizuoka Cancer Center.
He joined the National Center for Global Health and Medicine and has been the center’s Director since 2012.
In 2015, he earned an M.D. in clinical infectious diseases from the Graduate School of Medicine, Aichi Medical University.